Mesenchymal Stem Cells Market Players
Key players in the market are focusing on inorganic growth strategies such as acquisition and collaboration in order to expand its research and development activities and geographical presence. For instance in February 2019 Pluristem Therapeutics has collaborated with the NASA's Ames Research Center to evaluate the potential of Pluristem's PLX cell therapies in preventing and treating medical conditions caused during space missions. During space mission astronauts are exposed to a challenging environment that includes radiation and microgravity, leading to muscle and bone loss as well as other potentially serious medical conditions. The collaboration will explore the possibility that PLX placenta-based cell therapy products can address these and other persistent negative effects of space travel on the human body.
In February 2019, BrainStorm Cell Therapeutics Inc. announced to expand its clinical trial facility with Cleveland Clinic as the first U.S. clinical site contracted for a planned Phase 2 open-label, multicenter study of repeated intrathecal administration of autologous Mesenchymal Stem Cell (MSC-NTF) cells in participants with progressive Multiple Sclerosis (MS).
Moreover most of the key players are focusing on new product launch in the global mesenchymal stem cell market. For instance in February 2019, Cytonus Therapeutics has developed Cargocytes a first-of-its-kind, controllable, cell-based platform technology for delivery of biologics. Cargocytes are engineered allogenic cell lines that can carry a variety of small molecule compounds, gene editing therapies, therapeutic RNAs, and powerful biologics such as immune modulating cytokines, antibodies and oncolytic viruses. As a platform technology, cargocyte has many therapeutic applications and will be commercialized through a blend of internal and partnered programs.
Some of the key market players identified across the value chain of mesenchymal stem cells market are, Pluristem Therapeutics, LonzaThermo, Fisher, ATCC, Bio-Techne, MilliporeSigma, Genlantis, Celprogen, Cell Applications, PromoCell GmbH, Cyagen Biosciences, Human Longevity Inc., Axol Bioscience, Cytori Therapeutics, Eutilex Co.Ltd., ID Pharma Co. Ltd., BrainStrom Cell Therapeutics, Cytori Therapeutics Inc., Neovii Biotech, Angel Biotechnology, California Stem Cell Inc., Stemcelltechnologies Inc., and Celgene Corporation Inc.
Mesenchymal Stem Cells Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients